Wu C S, Lee N M, Loh H H, Yang J T
J Biol Chem. 1986 Mar 15;261(8):3687-91.
Circular dichroism was used as a probe for competitive binding of two opioid peptides, dynorphin-(1-13) and beta-endorphin, with cerebroside sulfate, a membrane lipid thought to be part of the morphine receptor complex. The rationale was that bound beta-endorphin is partially helical but bound dynorphin-(1-13) remains unordered, thus making it possible to detect the degree of binding of beta-endorphin. The addition of dynorphin-(1-13) to a cerebroside sulfate solution of beta-endorphin invariably displaced beta-endorphin from the peptide-lipid complex, but the addition of beta-endorphin had little effect on dynorphin-(1-13) bound to the lipid. Similar results were obtained for competitive binding of the two peptides with two other amphiphiles, sodium dodecyl and decyl sulfate. The maximum number of binding sites on dynorphin-(1-13) and beta-endorphin was between five and six, which coincides with the five positively charged side chains plus an alpha NH+3 group at the NH2 terminus on both peptide molecules. The results support our working hypothesis that dynorphin-(1-13) may displace beta-endorphin bound to the receptor, which in turn can account for the inhibition of beta-endorphin-induced analgesia by dynorphin-(1-13).
圆二色性被用作一种探针,用于研究两种阿片肽强啡肽-(1-13)和β-内啡肽与硫酸脑苷脂的竞争性结合,硫酸脑苷脂是一种被认为是吗啡受体复合物一部分的膜脂。其基本原理是,结合的β-内啡肽部分呈螺旋状,但结合的强啡肽-(1-13)仍无序,因此能够检测β-内啡肽的结合程度。将强啡肽-(1-13)添加到β-内啡肽的硫酸脑苷脂溶液中,总是会使β-内啡肽从肽-脂质复合物中被取代,但添加β-内啡肽对与脂质结合的强啡肽-(1-13)影响很小。两种肽与另外两种两亲物十二烷基硫酸钠和癸基硫酸钠的竞争性结合也得到了类似的结果。强啡肽-(1-13)和β-内啡肽上结合位点的最大数量在5到6个之间,这与两种肽分子上的五个带正电荷的侧链加上NH2末端的一个αNH+3基团相吻合。这些结果支持了我们的工作假设,即强啡肽-(1-13)可能取代与受体结合的β-内啡肽,这反过来可以解释强啡肽-(1-13)对β-内啡肽诱导的镇痛作用的抑制。